{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T18:20:55Z","timestamp":1778782855800,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Americas"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.lana.2026.101435","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T19:55:32Z","timestamp":1773258932000},"page":"101435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Burden of overdoses among persons with opioid use disorder in the United States, 2025\u20132028: a simulation modeling study"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0547-7214","authenticated-orcid":false,"given":"Nisha","family":"Nataraj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5316-4103","authenticated-orcid":false,"given":"Yijie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2666-8722","authenticated-orcid":false,"given":"S. Michaela","family":"Rikard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ketra","family":"Rice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine L.","family":"Mattson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Gery P.","family":"Guy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan L.","family":"Losby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lana.2026.101435_bib1","series-title":"Provisional drug overdose death counts","author":"Ahmad","year":"2025"},{"key":"10.1016\/j.lana.2026.101435_bib2","doi-asserted-by":"crossref","first-page":"r225","DOI":"10.1136\/bmj.r225","article-title":"Avoiding a new US \u201cwar on drugs\u201d","volume":"388","author":"Guilamo-Ramos","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.lana.2026.101435_bib3","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.15585\/mmwr.mm7348a2","article-title":"Detection of illegally manufactured fentanyls and carfentanil in drug overdose deaths\u2014United States, 2021\u20132024","volume":"73","author":"Tanz","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.lana.2026.101435_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.58090","article-title":"Recent drug overdose mortality decline compared with Pre\u2013COVID-19 trend","volume":"8","author":"Kiang","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.lana.2026.101435_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.4617","article-title":"Public health interventions and overdose-related outcomes among persons with opioid use disorder","volume":"7","author":"Nataraj","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.lana.2026.101435_bib6","series-title":"AnyLogic 8 Professional 8.7.10","year":"2022"},{"issue":"1","key":"10.1016\/j.lana.2026.101435_bib7","doi-asserted-by":"crossref","DOI":"10.1017\/S0266462321001732","article-title":"Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations","volume":"38","author":"Husereau","year":"2022","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.lana.2026.101435_bib8","series-title":"CDC's State Unintentional Drug Overdose Reporting System (S","article-title":"UDORS) 2024","year":"2025"},{"key":"10.1016\/j.lana.2026.101435_bib9","series-title":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2021 National Survey on Drug Use and Health","year":"2023"},{"key":"10.1016\/j.lana.2026.101435_bib10","series-title":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2022 National Survey on drug Use and Health","year":"2023"},{"key":"10.1016\/j.lana.2026.101435_bib11","series-title":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2023 National Survey on Drug Use and Health","year":"2024"},{"key":"10.1016\/j.lana.2026.101435_bib12","series-title":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2024 National Survey on Drug Use and Health","year":"2025"},{"key":"10.1016\/j.lana.2026.101435_bib13","series-title":"Medications for Opioid Use Disorder Study (MOUD Study)","year":"2022"},{"key":"10.1016\/j.lana.2026.101435_bib14","article-title":"What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size","volume":"3","author":"Keyes","year":"2022","journal-title":"Drug Alcohol Depend Rep"},{"key":"10.1016\/j.lana.2026.101435_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103786","article-title":"Has the treatment gap for opioid use disorder narrowed in the US?: a yearly assessment from 2010 to 2019","volume":"110","author":"Krawczyk","year":"2022","journal-title":"Int J Drug Policy"},{"issue":"25","key":"10.1016\/j.lana.2026.101435_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm8147","article-title":"Reducing opioid use disorder and overdose deaths in the United States: a dynamic modeling analysis","volume":"8","author":"Stringfellow","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.lana.2026.101435_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108350","article-title":"The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017","volume":"218","author":"Florence","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"10.1016\/j.lana.2026.101435_bib19","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/MLR.0000000000000625","article-title":"The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013","volume":"54","author":"Florence","year":"2016","journal-title":"Med Care"},{"key":"10.1016\/j.lana.2026.101435_bib20","series-title":"Stop Overdose","year":"2024"},{"key":"10.1016\/j.lana.2026.101435_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain\u2014United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.lana.2026.101435_bib23","series-title":"ENGAGE: Evidence-BASED Strategies to Prevent Youth Substance Use","year":"2025"},{"key":"10.1016\/j.lana.2026.101435_bib25","doi-asserted-by":"crossref","first-page":"567","DOI":"10.15585\/mmwr.mm7325a1","article-title":"Treatment for opioid use disorder: population estimates\u2014United States, 2022","volume":"73","author":"Dowell","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.lana.2026.101435_bib26","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/ADM.0000000000001457","article-title":"Individuals dispensed buprenorphine in the United States before and after federal Policy changes aimed at increasing access","volume":"19","author":"Guy","year":"2025","journal-title":"J Addict Med"},{"key":"10.1016\/j.lana.2026.101435_bib27","series-title":"CDC's State Unintentional Drug Overdose Reporting System (SUDORS) 2025","year":"2025"},{"key":"10.1016\/j.lana.2026.101435_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.06.038","article-title":"Impact of a community-based naloxone distribution program on opioid overdose death rates","volume":"204","author":"Naumann","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"10.1016\/j.lana.2026.101435_bib29","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1001\/jamainternmed.2024.1733","article-title":"Overdose, behavioral health services, and medications for opioid use disorder after a nonfatal overdose","volume":"184","author":"Jones","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"3","key":"10.1016\/j.lana.2026.101435_bib30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study","volume":"169","author":"Larochelle","year":"2018","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.lana.2026.101435_bib31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.annemergmed.2022.09.025","article-title":"Effectiveness of substance use navigation for emergency department patients with substance use disorders: an implementation study","volume":"81","author":"Anderson","year":"2023","journal-title":"Ann Emerg Med"},{"issue":"9","key":"10.1016\/j.lana.2026.101435_bib32","doi-asserted-by":"crossref","first-page":"e2431612","DOI":"10.1001\/jamanetworkopen.2024.31612","article-title":"Drug decriminalization, fentanyl, and fatal overdoses in Oregon","volume":"7","author":"Zoorob","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.lana.2026.101435_bib33","article-title":"Why have overdose deaths decreased? Widespread fentanyl saturation and decreased drug use among key drivers","volume":"51","author":"Dowell","year":"2025","journal-title":"Lancet Reg Health Am"},{"issue":"10","key":"10.1016\/j.lana.2026.101435_bib34","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.2105\/AJPH.2018.304590","article-title":"Modeling health benefits and harms of public policy responses to the US opioid epidemic","volume":"108","author":"Pitt","year":"2018","journal-title":"Am J Public Health"},{"issue":"2","key":"10.1016\/j.lana.2026.101435_bib35","doi-asserted-by":"crossref","first-page":"e2037259","DOI":"10.1001\/jamanetworkopen.2020.37259","article-title":"Projected estimates of opioid mortality after community-level interventions","volume":"4","author":"Linas","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.lana.2026.101435_bib36","series-title":"Wide-Ranging Online Data for Epidemiologic Research (WONDER)","year":"2025"}],"container-title":["The Lancet Regional Health - Americas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X26000657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X26000657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T08:32:38Z","timestamp":1775809958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667193X26000657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":33,"alternative-id":["S2667193X26000657"],"URL":"https:\/\/doi.org\/10.1016\/j.lana.2026.101435","relation":{},"ISSN":["2667-193X"],"issn-type":[{"value":"2667-193X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Burden of overdoses among persons with opioid use disorder in the United States, 2025\u20132028: a simulation modeling study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Americas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lana.2026.101435","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101435"}}